ArticleBMC nephrology2024

Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study.

Gurdeep Singh Dhooria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.